PMC:7283670 / 56463-56585 JSONTXT

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T342","span":{"begin":66,"end":74},"obj":"Disease"}],"attributes":[{"id":"A342","pred":"mondo_id","subj":"T342","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"}],"text":"Recombinant human angiotensin‐converting enzyme 2 (rhACE2) China/COVID‐19 24, all, 18–80 Treatment Experimental group:"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T543","span":{"begin":12,"end":17},"obj":"http://purl.obolibrary.org/obo/NCBITaxon_9606"},{"id":"T544","span":{"begin":85,"end":87},"obj":"http://purl.obolibrary.org/obo/CLO_0050510"}],"text":"Recombinant human angiotensin‐converting enzyme 2 (rhACE2) China/COVID‐19 24, all, 18–80 Treatment Experimental group:"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T17203","span":{"begin":18,"end":29},"obj":"Chemical"},{"id":"T28054","span":{"begin":116,"end":121},"obj":"Chemical"}],"attributes":[{"id":"A42372","pred":"chebi_id","subj":"T17203","obj":"http://purl.obolibrary.org/obo/CHEBI_48433"},{"id":"A71151","pred":"chebi_id","subj":"T28054","obj":"http://purl.obolibrary.org/obo/CHEBI_24433"}],"text":"Recombinant human angiotensin‐converting enzyme 2 (rhACE2) China/COVID‐19 24, all, 18–80 Treatment Experimental group:"}

{"project":"LitCovid-sentences","denotations":[{"id":"T614","span":{"begin":0,"end":122},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Recombinant human angiotensin‐converting enzyme 2 (rhACE2) China/COVID‐19 24, all, 18–80 Treatment Experimental group:"}

{"project":"LitCovid-PubTator","denotations":[{"id":"1808","span":{"begin":18,"end":49},"obj":"Gene"},{"id":"1882","span":{"begin":12,"end":17},"obj":"Species"},{"id":"2098","span":{"begin":66,"end":74},"obj":"Disease"}],"attributes":[{"id":"A1808","pred":"tao:has_database_id","subj":"1808","obj":"Gene:59272"},{"id":"A1882","pred":"tao:has_database_id","subj":"1882","obj":"Tax:9606"},{"id":"A2098","pred":"tao:has_database_id","subj":"2098","obj":"MESH:C000657245"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Recombinant human angiotensin‐converting enzyme 2 (rhACE2) China/COVID‐19 24, all, 18–80 Treatment Experimental group:"}